nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—Benazepril—MTHFR—stomach cancer	0.00858	0.551	CrCbGaD
Solifenacin—Benazepril—ACE—stomach cancer	0.007	0.449	CrCbGaD
Solifenacin—Decreased appetite—Irinotecan—stomach cancer	0.00141	0.00205	CcSEcCtD
Solifenacin—Abdominal pain upper—Epirubicin—stomach cancer	0.00141	0.00205	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Irinotecan—stomach cancer	0.0014	0.00204	CcSEcCtD
Solifenacin—Fatigue—Irinotecan—stomach cancer	0.0014	0.00204	CcSEcCtD
Solifenacin—Constipation—Irinotecan—stomach cancer	0.00139	0.00202	CcSEcCtD
Solifenacin—Angiopathy—Capecitabine—stomach cancer	0.00139	0.00202	CcSEcCtD
Solifenacin—Mental disorder—Docetaxel—stomach cancer	0.00138	0.00201	CcSEcCtD
Solifenacin—Somnolence—Fluorouracil—stomach cancer	0.00138	0.00201	CcSEcCtD
Solifenacin—Immune system disorder—Capecitabine—stomach cancer	0.00138	0.00201	CcSEcCtD
Solifenacin—Mediastinal disorder—Capecitabine—stomach cancer	0.00138	0.002	CcSEcCtD
Solifenacin—Malnutrition—Docetaxel—stomach cancer	0.00138	0.002	CcSEcCtD
Solifenacin—Dyspepsia—Fluorouracil—stomach cancer	0.00137	0.00199	CcSEcCtD
Solifenacin—Muscular weakness—Epirubicin—stomach cancer	0.00136	0.00198	CcSEcCtD
Solifenacin—Decreased appetite—Fluorouracil—stomach cancer	0.00135	0.00197	CcSEcCtD
Solifenacin—Dysgeusia—Docetaxel—stomach cancer	0.00135	0.00196	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00134	0.00195	CcSEcCtD
Solifenacin—Mental disorder—Capecitabine—stomach cancer	0.00134	0.00195	CcSEcCtD
Solifenacin—Feeling abnormal—Irinotecan—stomach cancer	0.00134	0.00195	CcSEcCtD
Solifenacin—Malnutrition—Capecitabine—stomach cancer	0.00133	0.00194	CcSEcCtD
Solifenacin—Influenza—Epirubicin—stomach cancer	0.00133	0.00194	CcSEcCtD
Solifenacin—Dysuria—Methotrexate—stomach cancer	0.00133	0.00193	CcSEcCtD
Solifenacin—Gastrointestinal pain—Irinotecan—stomach cancer	0.00133	0.00193	CcSEcCtD
Solifenacin—Liver function test abnormal—Doxorubicin—stomach cancer	0.00132	0.00191	CcSEcCtD
Solifenacin—Dry skin—Doxorubicin—stomach cancer	0.00131	0.0019	CcSEcCtD
Solifenacin—Dysgeusia—Capecitabine—stomach cancer	0.0013	0.0019	CcSEcCtD
Solifenacin—Abdominal pain upper—Doxorubicin—stomach cancer	0.0013	0.00189	CcSEcCtD
Solifenacin—Abdominal pain—Irinotecan—stomach cancer	0.00128	0.00187	CcSEcCtD
Solifenacin—Feeling abnormal—Fluorouracil—stomach cancer	0.00128	0.00186	CcSEcCtD
Solifenacin—Infestation—Methotrexate—stomach cancer	0.00127	0.00184	CcSEcCtD
Solifenacin—Infestation NOS—Methotrexate—stomach cancer	0.00127	0.00184	CcSEcCtD
Solifenacin—Depression—Methotrexate—stomach cancer	0.00126	0.00184	CcSEcCtD
Solifenacin—Muscular weakness—Doxorubicin—stomach cancer	0.00126	0.00183	CcSEcCtD
Solifenacin—Vision blurred—Capecitabine—stomach cancer	0.00125	0.00183	CcSEcCtD
Solifenacin—Renal failure—Methotrexate—stomach cancer	0.00125	0.00181	CcSEcCtD
Solifenacin—Dysuria—Epirubicin—stomach cancer	0.00124	0.00181	CcSEcCtD
Solifenacin—Urticaria—Fluorouracil—stomach cancer	0.00124	0.0018	CcSEcCtD
Solifenacin—Influenza—Doxorubicin—stomach cancer	0.00123	0.00179	CcSEcCtD
Solifenacin—Palpitations—Docetaxel—stomach cancer	0.00122	0.00177	CcSEcCtD
Solifenacin—Cough—Docetaxel—stomach cancer	0.0012	0.00175	CcSEcCtD
Solifenacin—Hepatobiliary disease—Methotrexate—stomach cancer	0.0012	0.00174	CcSEcCtD
Solifenacin—Hypersensitivity—Irinotecan—stomach cancer	0.0012	0.00174	CcSEcCtD
Solifenacin—Hypertension—Docetaxel—stomach cancer	0.00119	0.00173	CcSEcCtD
Solifenacin—Infestation NOS—Epirubicin—stomach cancer	0.00119	0.00173	CcSEcCtD
Solifenacin—Infestation—Epirubicin—stomach cancer	0.00119	0.00173	CcSEcCtD
Solifenacin—Palpitations—Capecitabine—stomach cancer	0.00118	0.00171	CcSEcCtD
Solifenacin—Renal failure—Epirubicin—stomach cancer	0.00117	0.0017	CcSEcCtD
Solifenacin—Asthenia—Irinotecan—stomach cancer	0.00116	0.00169	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00116	0.00169	CcSEcCtD
Solifenacin—Cough—Capecitabine—stomach cancer	0.00116	0.00169	CcSEcCtD
Solifenacin—Urinary tract infection—Epirubicin—stomach cancer	0.00115	0.00168	CcSEcCtD
Solifenacin—Dysuria—Doxorubicin—stomach cancer	0.00115	0.00168	CcSEcCtD
Solifenacin—Hypertension—Capecitabine—stomach cancer	0.00115	0.00167	CcSEcCtD
Solifenacin—Hypersensitivity—Fluorouracil—stomach cancer	0.00115	0.00167	CcSEcCtD
Solifenacin—Dry mouth—Docetaxel—stomach cancer	0.00114	0.00167	CcSEcCtD
Solifenacin—Confusional state—Docetaxel—stomach cancer	0.00113	0.00165	CcSEcCtD
Solifenacin—Pharyngitis—Methotrexate—stomach cancer	0.00113	0.00164	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00113	0.00164	CcSEcCtD
Solifenacin—Urinary tract disorder—Methotrexate—stomach cancer	0.00112	0.00164	CcSEcCtD
Solifenacin—Hepatobiliary disease—Epirubicin—stomach cancer	0.00112	0.00163	CcSEcCtD
Solifenacin—Anaphylactic shock—Docetaxel—stomach cancer	0.00112	0.00163	CcSEcCtD
Solifenacin—Urethral disorder—Methotrexate—stomach cancer	0.00112	0.00162	CcSEcCtD
Solifenacin—Infection—Docetaxel—stomach cancer	0.00111	0.00162	CcSEcCtD
Solifenacin—Dry mouth—Capecitabine—stomach cancer	0.00111	0.00161	CcSEcCtD
Solifenacin—Nervous system disorder—Docetaxel—stomach cancer	0.0011	0.0016	CcSEcCtD
Solifenacin—Pruritus—Fluorouracil—stomach cancer	0.0011	0.0016	CcSEcCtD
Solifenacin—Infestation NOS—Doxorubicin—stomach cancer	0.0011	0.0016	CcSEcCtD
Solifenacin—Infestation—Doxorubicin—stomach cancer	0.0011	0.0016	CcSEcCtD
Solifenacin—Confusional state—Capecitabine—stomach cancer	0.0011	0.00159	CcSEcCtD
Solifenacin—Tachycardia—Docetaxel—stomach cancer	0.0011	0.00159	CcSEcCtD
Solifenacin—Skin disorder—Docetaxel—stomach cancer	0.00109	0.00159	CcSEcCtD
Solifenacin—Renal failure—Doxorubicin—stomach cancer	0.00108	0.00157	CcSEcCtD
Solifenacin—Infection—Capecitabine—stomach cancer	0.00108	0.00157	CcSEcCtD
Solifenacin—Erythema multiforme—Methotrexate—stomach cancer	0.00108	0.00157	CcSEcCtD
Solifenacin—Dizziness—Irinotecan—stomach cancer	0.00107	0.00156	CcSEcCtD
Solifenacin—Urinary tract infection—Doxorubicin—stomach cancer	0.00107	0.00155	CcSEcCtD
Solifenacin—Nervous system disorder—Capecitabine—stomach cancer	0.00107	0.00155	CcSEcCtD
Solifenacin—Eye disorder—Methotrexate—stomach cancer	0.00106	0.00155	CcSEcCtD
Solifenacin—Tachycardia—Capecitabine—stomach cancer	0.00106	0.00154	CcSEcCtD
Solifenacin—Pharyngitis—Epirubicin—stomach cancer	0.00106	0.00154	CcSEcCtD
Solifenacin—Cardiac disorder—Methotrexate—stomach cancer	0.00106	0.00154	CcSEcCtD
Solifenacin—Skin disorder—Capecitabine—stomach cancer	0.00106	0.00154	CcSEcCtD
Solifenacin—Urinary tract disorder—Epirubicin—stomach cancer	0.00105	0.00153	CcSEcCtD
Solifenacin—Oedema peripheral—Epirubicin—stomach cancer	0.00105	0.00153	CcSEcCtD
Solifenacin—Connective tissue disorder—Epirubicin—stomach cancer	0.00105	0.00152	CcSEcCtD
Solifenacin—Urethral disorder—Epirubicin—stomach cancer	0.00104	0.00152	CcSEcCtD
Solifenacin—Hepatobiliary disease—Doxorubicin—stomach cancer	0.00104	0.00151	CcSEcCtD
Solifenacin—Angiopathy—Methotrexate—stomach cancer	0.00103	0.0015	CcSEcCtD
Solifenacin—Vomiting—Irinotecan—stomach cancer	0.00103	0.0015	CcSEcCtD
Solifenacin—Immune system disorder—Methotrexate—stomach cancer	0.00103	0.0015	CcSEcCtD
Solifenacin—Dizziness—Fluorouracil—stomach cancer	0.00103	0.0015	CcSEcCtD
Solifenacin—Mediastinal disorder—Methotrexate—stomach cancer	0.00103	0.00149	CcSEcCtD
Solifenacin—Rash—Irinotecan—stomach cancer	0.00102	0.00149	CcSEcCtD
Solifenacin—Dermatitis—Irinotecan—stomach cancer	0.00102	0.00149	CcSEcCtD
Solifenacin—Headache—Irinotecan—stomach cancer	0.00102	0.00148	CcSEcCtD
Solifenacin—Erythema multiforme—Epirubicin—stomach cancer	0.00101	0.00147	CcSEcCtD
Solifenacin—Somnolence—Docetaxel—stomach cancer	0.000998	0.00145	CcSEcCtD
Solifenacin—Mental disorder—Methotrexate—stomach cancer	0.000997	0.00145	CcSEcCtD
Solifenacin—Eye disorder—Epirubicin—stomach cancer	0.000996	0.00145	CcSEcCtD
Solifenacin—Malnutrition—Methotrexate—stomach cancer	0.000991	0.00144	CcSEcCtD
Solifenacin—Cardiac disorder—Epirubicin—stomach cancer	0.000989	0.00144	CcSEcCtD
Solifenacin—Vomiting—Fluorouracil—stomach cancer	0.000989	0.00144	CcSEcCtD
Solifenacin—Dyspepsia—Docetaxel—stomach cancer	0.000988	0.00144	CcSEcCtD
Solifenacin—Rash—Fluorouracil—stomach cancer	0.00098	0.00143	CcSEcCtD
Solifenacin—Dermatitis—Fluorouracil—stomach cancer	0.000979	0.00142	CcSEcCtD
Solifenacin—Pharyngitis—Doxorubicin—stomach cancer	0.000978	0.00142	CcSEcCtD
Solifenacin—Decreased appetite—Docetaxel—stomach cancer	0.000976	0.00142	CcSEcCtD
Solifenacin—Headache—Fluorouracil—stomach cancer	0.000974	0.00142	CcSEcCtD
Solifenacin—Urinary tract disorder—Doxorubicin—stomach cancer	0.000974	0.00142	CcSEcCtD
Solifenacin—Oedema peripheral—Doxorubicin—stomach cancer	0.000971	0.00141	CcSEcCtD
Solifenacin—Dysgeusia—Methotrexate—stomach cancer	0.000971	0.00141	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000969	0.00141	CcSEcCtD
Solifenacin—Connective tissue disorder—Doxorubicin—stomach cancer	0.000969	0.00141	CcSEcCtD
Solifenacin—Fatigue—Docetaxel—stomach cancer	0.000968	0.00141	CcSEcCtD
Solifenacin—Angiopathy—Epirubicin—stomach cancer	0.000967	0.00141	CcSEcCtD
Solifenacin—Urethral disorder—Doxorubicin—stomach cancer	0.000966	0.00141	CcSEcCtD
Solifenacin—Nausea—Irinotecan—stomach cancer	0.000964	0.0014	CcSEcCtD
Solifenacin—Immune system disorder—Epirubicin—stomach cancer	0.000962	0.0014	CcSEcCtD
Solifenacin—Mediastinal disorder—Epirubicin—stomach cancer	0.00096	0.0014	CcSEcCtD
Solifenacin—Constipation—Docetaxel—stomach cancer	0.00096	0.0014	CcSEcCtD
Solifenacin—Dyspepsia—Capecitabine—stomach cancer	0.000956	0.00139	CcSEcCtD
Solifenacin—Decreased appetite—Capecitabine—stomach cancer	0.000945	0.00137	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000938	0.00136	CcSEcCtD
Solifenacin—Fatigue—Capecitabine—stomach cancer	0.000937	0.00136	CcSEcCtD
Solifenacin—Vision blurred—Methotrexate—stomach cancer	0.000934	0.00136	CcSEcCtD
Solifenacin—Mental disorder—Epirubicin—stomach cancer	0.000933	0.00136	CcSEcCtD
Solifenacin—Erythema multiforme—Doxorubicin—stomach cancer	0.000932	0.00136	CcSEcCtD
Solifenacin—Constipation—Capecitabine—stomach cancer	0.000929	0.00135	CcSEcCtD
Solifenacin—Malnutrition—Epirubicin—stomach cancer	0.000928	0.00135	CcSEcCtD
Solifenacin—Feeling abnormal—Docetaxel—stomach cancer	0.000925	0.00135	CcSEcCtD
Solifenacin—Nausea—Fluorouracil—stomach cancer	0.000924	0.00134	CcSEcCtD
Solifenacin—Eye disorder—Doxorubicin—stomach cancer	0.000921	0.00134	CcSEcCtD
Solifenacin—Gastrointestinal pain—Docetaxel—stomach cancer	0.000918	0.00133	CcSEcCtD
Solifenacin—Cardiac disorder—Doxorubicin—stomach cancer	0.000915	0.00133	CcSEcCtD
Solifenacin—Dysgeusia—Epirubicin—stomach cancer	0.000908	0.00132	CcSEcCtD
Solifenacin—Feeling abnormal—Capecitabine—stomach cancer	0.000895	0.0013	CcSEcCtD
Solifenacin—Angiopathy—Doxorubicin—stomach cancer	0.000894	0.0013	CcSEcCtD
Solifenacin—Immune system disorder—Doxorubicin—stomach cancer	0.00089	0.0013	CcSEcCtD
Solifenacin—Gastrointestinal pain—Capecitabine—stomach cancer	0.000889	0.00129	CcSEcCtD
Solifenacin—Mediastinal disorder—Doxorubicin—stomach cancer	0.000889	0.00129	CcSEcCtD
Solifenacin—Abdominal pain—Docetaxel—stomach cancer	0.000887	0.00129	CcSEcCtD
Solifenacin—Vision blurred—Epirubicin—stomach cancer	0.000874	0.00127	CcSEcCtD
Solifenacin—Cough—Methotrexate—stomach cancer	0.000865	0.00126	CcSEcCtD
Solifenacin—Mental disorder—Doxorubicin—stomach cancer	0.000864	0.00126	CcSEcCtD
Solifenacin—Urticaria—Capecitabine—stomach cancer	0.000863	0.00126	CcSEcCtD
Solifenacin—Abdominal pain—Capecitabine—stomach cancer	0.000859	0.00125	CcSEcCtD
Solifenacin—Malnutrition—Doxorubicin—stomach cancer	0.000858	0.00125	CcSEcCtD
Solifenacin—Dysgeusia—Doxorubicin—stomach cancer	0.00084	0.00122	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000838	0.00122	CcSEcCtD
Solifenacin—Hypersensitivity—Docetaxel—stomach cancer	0.000827	0.0012	CcSEcCtD
Solifenacin—Palpitations—Epirubicin—stomach cancer	0.00082	0.00119	CcSEcCtD
Solifenacin—Confusional state—Methotrexate—stomach cancer	0.000816	0.00119	CcSEcCtD
Solifenacin—Cough—Epirubicin—stomach cancer	0.000809	0.00118	CcSEcCtD
Solifenacin—Anaphylactic shock—Methotrexate—stomach cancer	0.000809	0.00118	CcSEcCtD
Solifenacin—Vision blurred—Doxorubicin—stomach cancer	0.000809	0.00118	CcSEcCtD
Solifenacin—Asthenia—Docetaxel—stomach cancer	0.000805	0.00117	CcSEcCtD
Solifenacin—Infection—Methotrexate—stomach cancer	0.000804	0.00117	CcSEcCtD
Solifenacin—Hypertension—Epirubicin—stomach cancer	0.000801	0.00116	CcSEcCtD
Solifenacin—Hypersensitivity—Capecitabine—stomach cancer	0.000801	0.00116	CcSEcCtD
Solifenacin—Pruritus—Docetaxel—stomach cancer	0.000794	0.00115	CcSEcCtD
Solifenacin—Nervous system disorder—Methotrexate—stomach cancer	0.000793	0.00115	CcSEcCtD
Solifenacin—Skin disorder—Methotrexate—stomach cancer	0.000786	0.00114	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000784	0.00114	CcSEcCtD
Solifenacin—Asthenia—Capecitabine—stomach cancer	0.00078	0.00113	CcSEcCtD
Solifenacin—Dry mouth—Epirubicin—stomach cancer	0.000772	0.00112	CcSEcCtD
Solifenacin—Pruritus—Capecitabine—stomach cancer	0.000769	0.00112	CcSEcCtD
Solifenacin—Confusional state—Epirubicin—stomach cancer	0.000763	0.00111	CcSEcCtD
Solifenacin—Palpitations—Doxorubicin—stomach cancer	0.000758	0.0011	CcSEcCtD
Solifenacin—Anaphylactic shock—Epirubicin—stomach cancer	0.000757	0.0011	CcSEcCtD
Solifenacin—Infection—Epirubicin—stomach cancer	0.000752	0.00109	CcSEcCtD
Solifenacin—Cough—Doxorubicin—stomach cancer	0.000749	0.00109	CcSEcCtD
Solifenacin—Nervous system disorder—Epirubicin—stomach cancer	0.000742	0.00108	CcSEcCtD
Solifenacin—Dizziness—Docetaxel—stomach cancer	0.000742	0.00108	CcSEcCtD
Solifenacin—Hypertension—Doxorubicin—stomach cancer	0.000741	0.00108	CcSEcCtD
Solifenacin—Tachycardia—Epirubicin—stomach cancer	0.000739	0.00107	CcSEcCtD
Solifenacin—Skin disorder—Epirubicin—stomach cancer	0.000735	0.00107	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000726	0.00106	CcSEcCtD
Solifenacin—Somnolence—Methotrexate—stomach cancer	0.000719	0.00105	CcSEcCtD
Solifenacin—Dizziness—Capecitabine—stomach cancer	0.000719	0.00105	CcSEcCtD
Solifenacin—Dry mouth—Doxorubicin—stomach cancer	0.000715	0.00104	CcSEcCtD
Solifenacin—Vomiting—Docetaxel—stomach cancer	0.000714	0.00104	CcSEcCtD
Solifenacin—Dyspepsia—Methotrexate—stomach cancer	0.000712	0.00104	CcSEcCtD
Solifenacin—Rash—Docetaxel—stomach cancer	0.000708	0.00103	CcSEcCtD
Solifenacin—Dermatitis—Docetaxel—stomach cancer	0.000707	0.00103	CcSEcCtD
Solifenacin—Confusional state—Doxorubicin—stomach cancer	0.000706	0.00103	CcSEcCtD
Solifenacin—Decreased appetite—Methotrexate—stomach cancer	0.000703	0.00102	CcSEcCtD
Solifenacin—Headache—Docetaxel—stomach cancer	0.000703	0.00102	CcSEcCtD
Solifenacin—Anaphylactic shock—Doxorubicin—stomach cancer	0.0007	0.00102	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000698	0.00102	CcSEcCtD
Solifenacin—Fatigue—Methotrexate—stomach cancer	0.000697	0.00101	CcSEcCtD
Solifenacin—Infection—Doxorubicin—stomach cancer	0.000696	0.00101	CcSEcCtD
Solifenacin—Vomiting—Capecitabine—stomach cancer	0.000691	0.001	CcSEcCtD
Solifenacin—Nervous system disorder—Doxorubicin—stomach cancer	0.000687	0.000999	CcSEcCtD
Solifenacin—Rash—Capecitabine—stomach cancer	0.000685	0.000997	CcSEcCtD
Solifenacin—Dermatitis—Capecitabine—stomach cancer	0.000684	0.000996	CcSEcCtD
Solifenacin—Tachycardia—Doxorubicin—stomach cancer	0.000684	0.000994	CcSEcCtD
Solifenacin—Headache—Capecitabine—stomach cancer	0.000681	0.00099	CcSEcCtD
Solifenacin—Skin disorder—Doxorubicin—stomach cancer	0.00068	0.00099	CcSEcCtD
Solifenacin—Somnolence—Epirubicin—stomach cancer	0.000673	0.000979	CcSEcCtD
Solifenacin—Nausea—Docetaxel—stomach cancer	0.000667	0.00097	CcSEcCtD
Solifenacin—Feeling abnormal—Methotrexate—stomach cancer	0.000667	0.00097	CcSEcCtD
Solifenacin—Dyspepsia—Epirubicin—stomach cancer	0.000666	0.000969	CcSEcCtD
Solifenacin—Gastrointestinal pain—Methotrexate—stomach cancer	0.000661	0.000962	CcSEcCtD
Solifenacin—Decreased appetite—Epirubicin—stomach cancer	0.000658	0.000957	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000654	0.000951	CcSEcCtD
Solifenacin—Fatigue—Epirubicin—stomach cancer	0.000653	0.000949	CcSEcCtD
Solifenacin—Constipation—Epirubicin—stomach cancer	0.000647	0.000942	CcSEcCtD
Solifenacin—Nausea—Capecitabine—stomach cancer	0.000645	0.000939	CcSEcCtD
Solifenacin—Urticaria—Methotrexate—stomach cancer	0.000643	0.000935	CcSEcCtD
Solifenacin—Abdominal pain—Methotrexate—stomach cancer	0.000639	0.00093	CcSEcCtD
Solifenacin—Feeling abnormal—Epirubicin—stomach cancer	0.000624	0.000907	CcSEcCtD
Solifenacin—Somnolence—Doxorubicin—stomach cancer	0.000623	0.000906	CcSEcCtD
Solifenacin—Gastrointestinal pain—Epirubicin—stomach cancer	0.000619	0.0009	CcSEcCtD
Solifenacin—Dyspepsia—Doxorubicin—stomach cancer	0.000617	0.000897	CcSEcCtD
Solifenacin—Decreased appetite—Doxorubicin—stomach cancer	0.000609	0.000886	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000605	0.00088	CcSEcCtD
Solifenacin—Fatigue—Doxorubicin—stomach cancer	0.000604	0.000878	CcSEcCtD
Solifenacin—Urticaria—Epirubicin—stomach cancer	0.000601	0.000875	CcSEcCtD
Solifenacin—Constipation—Doxorubicin—stomach cancer	0.000599	0.000871	CcSEcCtD
Solifenacin—Abdominal pain—Epirubicin—stomach cancer	0.000598	0.00087	CcSEcCtD
Solifenacin—Hypersensitivity—Methotrexate—stomach cancer	0.000596	0.000867	CcSEcCtD
Solifenacin—Asthenia—Methotrexate—stomach cancer	0.00058	0.000844	CcSEcCtD
Solifenacin—Feeling abnormal—Doxorubicin—stomach cancer	0.000577	0.00084	CcSEcCtD
Solifenacin—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000573	0.000833	CcSEcCtD
Solifenacin—Pruritus—Methotrexate—stomach cancer	0.000572	0.000832	CcSEcCtD
Solifenacin—Hypersensitivity—Epirubicin—stomach cancer	0.000558	0.000811	CcSEcCtD
Solifenacin—Urticaria—Doxorubicin—stomach cancer	0.000556	0.000809	CcSEcCtD
Solifenacin—Abdominal pain—Doxorubicin—stomach cancer	0.000554	0.000805	CcSEcCtD
Solifenacin—Asthenia—Epirubicin—stomach cancer	0.000543	0.00079	CcSEcCtD
Solifenacin—Pruritus—Epirubicin—stomach cancer	0.000536	0.000779	CcSEcCtD
Solifenacin—Dizziness—Methotrexate—stomach cancer	0.000535	0.000778	CcSEcCtD
Solifenacin—Hypersensitivity—Doxorubicin—stomach cancer	0.000516	0.000751	CcSEcCtD
Solifenacin—Vomiting—Methotrexate—stomach cancer	0.000514	0.000748	CcSEcCtD
Solifenacin—Rash—Methotrexate—stomach cancer	0.00051	0.000742	CcSEcCtD
Solifenacin—Dermatitis—Methotrexate—stomach cancer	0.00051	0.000741	CcSEcCtD
Solifenacin—Headache—Methotrexate—stomach cancer	0.000507	0.000737	CcSEcCtD
Solifenacin—Asthenia—Doxorubicin—stomach cancer	0.000503	0.000731	CcSEcCtD
Solifenacin—Dizziness—Epirubicin—stomach cancer	0.000501	0.000728	CcSEcCtD
Solifenacin—Pruritus—Doxorubicin—stomach cancer	0.000496	0.000721	CcSEcCtD
Solifenacin—Vomiting—Epirubicin—stomach cancer	0.000481	0.0007	CcSEcCtD
Solifenacin—Nausea—Methotrexate—stomach cancer	0.00048	0.000699	CcSEcCtD
Solifenacin—Rash—Epirubicin—stomach cancer	0.000477	0.000694	CcSEcCtD
Solifenacin—Dermatitis—Epirubicin—stomach cancer	0.000477	0.000694	CcSEcCtD
Solifenacin—Headache—Epirubicin—stomach cancer	0.000474	0.00069	CcSEcCtD
Solifenacin—Dizziness—Doxorubicin—stomach cancer	0.000463	0.000674	CcSEcCtD
Solifenacin—Nausea—Epirubicin—stomach cancer	0.00045	0.000654	CcSEcCtD
Solifenacin—Vomiting—Doxorubicin—stomach cancer	0.000445	0.000648	CcSEcCtD
Solifenacin—Rash—Doxorubicin—stomach cancer	0.000442	0.000642	CcSEcCtD
Solifenacin—Dermatitis—Doxorubicin—stomach cancer	0.000441	0.000642	CcSEcCtD
Solifenacin—Headache—Doxorubicin—stomach cancer	0.000439	0.000638	CcSEcCtD
Solifenacin—Nausea—Doxorubicin—stomach cancer	0.000416	0.000605	CcSEcCtD
Solifenacin—CYP3A4—Metabolism—UMPS—stomach cancer	6e-05	0.000202	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—GSTM1—stomach cancer	5.99e-05	0.000202	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL6R—stomach cancer	5.86e-05	0.000198	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL6R—stomach cancer	5.85e-05	0.000197	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—RHOA—stomach cancer	5.83e-05	0.000196	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CAV1—stomach cancer	5.82e-05	0.000196	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—RHOA—stomach cancer	5.81e-05	0.000196	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—APOA1—stomach cancer	5.8e-05	0.000195	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL6R—stomach cancer	5.79e-05	0.000195	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PRKCB—stomach cancer	5.78e-05	0.000195	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL6ST—stomach cancer	5.76e-05	0.000194	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—RHOA—stomach cancer	5.76e-05	0.000194	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ADRB2—stomach cancer	5.69e-05	0.000192	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ADRB2—stomach cancer	5.67e-05	0.000191	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ERCC2—stomach cancer	5.63e-05	0.00019	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ADRB2—stomach cancer	5.62e-05	0.000189	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ECHS1—stomach cancer	5.58e-05	0.000188	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PDHA1—stomach cancer	5.58e-05	0.000188	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PPP2R1A—stomach cancer	5.57e-05	0.000188	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PPP2R1A—stomach cancer	5.56e-05	0.000187	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PRKCB—stomach cancer	5.54e-05	0.000186	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—APC—stomach cancer	5.53e-05	0.000186	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL6ST—stomach cancer	5.51e-05	0.000186	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PPP2R1A—stomach cancer	5.5e-05	0.000185	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—MAPK3—stomach cancer	5.3e-05	0.000178	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—APC—stomach cancer	5.3e-05	0.000178	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—RHOA—stomach cancer	5.3e-05	0.000178	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—MTHFR—stomach cancer	5.29e-05	0.000178	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—RHOA—stomach cancer	5.28e-05	0.000178	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—TYMP—stomach cancer	5.24e-05	0.000177	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—FADS1—stomach cancer	5.24e-05	0.000177	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—RHOA—stomach cancer	5.23e-05	0.000176	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SMAD4—stomach cancer	5.18e-05	0.000174	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SMAD4—stomach cancer	5.16e-05	0.000174	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL6R—stomach cancer	5.14e-05	0.000173	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CXCL8—stomach cancer	5.12e-05	0.000172	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SMAD4—stomach cancer	5.11e-05	0.000172	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CXCL8—stomach cancer	5.1e-05	0.000172	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—MAPK3—stomach cancer	5.07e-05	0.000171	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CXCL8—stomach cancer	5.06e-05	0.00017	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—MAPK1—stomach cancer	5.04e-05	0.00017	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—EGFR—stomach cancer	5.04e-05	0.00017	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL6R—stomach cancer	4.92e-05	0.000166	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—FYN—stomach cancer	4.91e-05	0.000166	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—SREBF2—stomach cancer	4.91e-05	0.000165	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—FYN—stomach cancer	4.9e-05	0.000165	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CAV1—stomach cancer	4.88e-05	0.000164	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—APOA1—stomach cancer	4.87e-05	0.000164	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—FYN—stomach cancer	4.85e-05	0.000163	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—RORA—stomach cancer	4.85e-05	0.000163	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—MAPK1—stomach cancer	4.83e-05	0.000163	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—EGFR—stomach cancer	4.83e-05	0.000163	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—PIK3CA—stomach cancer	4.82e-05	0.000162	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—SERPINE1—stomach cancer	4.81e-05	0.000162	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—KRAS—stomach cancer	4.76e-05	0.00016	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CXCL8—stomach cancer	4.65e-05	0.000157	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—RHOA—stomach cancer	4.64e-05	0.000156	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CXCL8—stomach cancer	4.64e-05	0.000156	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—PIK3CA—stomach cancer	4.61e-05	0.000155	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—FGFR2—stomach cancer	4.61e-05	0.000155	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—SERPINE1—stomach cancer	4.61e-05	0.000155	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—FGFR2—stomach cancer	4.6e-05	0.000155	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NOS3—stomach cancer	4.59e-05	0.000155	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CXCL8—stomach cancer	4.59e-05	0.000155	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—KRAS—stomach cancer	4.56e-05	0.000154	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—FGFR2—stomach cancer	4.55e-05	0.000153	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ALDOB—stomach cancer	4.55e-05	0.000153	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—RHOA—stomach cancer	4.44e-05	0.00015	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NOS3—stomach cancer	4.4e-05	0.000148	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—PIK3CA—stomach cancer	4.38e-05	0.000147	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—ERBB2—stomach cancer	4.3e-05	0.000145	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PPARG—stomach cancer	4.29e-05	0.000145	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ALOX5—stomach cancer	4.23e-05	0.000142	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IRS2—stomach cancer	4.22e-05	0.000142	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IRS2—stomach cancer	4.21e-05	0.000142	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—PIK3CA—stomach cancer	4.19e-05	0.000141	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IRS2—stomach cancer	4.17e-05	0.00014	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—DPYD—stomach cancer	4.16e-05	0.00014	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—ERBB2—stomach cancer	4.11e-05	0.000139	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CAV1—stomach cancer	4.1e-05	0.000138	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—APOA1—stomach cancer	4.09e-05	0.000138	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CAV1—stomach cancer	4.08e-05	0.000138	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CXCL8—stomach cancer	4.07e-05	0.000137	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—APOA1—stomach cancer	4.07e-05	0.000137	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—HRAS—stomach cancer	4.05e-05	0.000136	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CAV1—stomach cancer	4.04e-05	0.000136	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—APOA1—stomach cancer	4.03e-05	0.000136	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CDKN1B—stomach cancer	3.98e-05	0.000134	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CXCL8—stomach cancer	3.9e-05	0.000131	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PRKCB—stomach cancer	3.9e-05	0.000131	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PRKCB—stomach cancer	3.89e-05	0.000131	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL6ST—stomach cancer	3.88e-05	0.000131	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—HRAS—stomach cancer	3.88e-05	0.000131	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—IL6—stomach cancer	3.87e-05	0.00013	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL6ST—stomach cancer	3.87e-05	0.00013	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ALB—stomach cancer	3.86e-05	0.00013	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PRKCB—stomach cancer	3.85e-05	0.00013	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL6ST—stomach cancer	3.83e-05	0.000129	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CDKN1B—stomach cancer	3.81e-05	0.000128	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CCND1—stomach cancer	3.8e-05	0.000128	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—JUN—stomach cancer	3.79e-05	0.000128	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—APC—stomach cancer	3.73e-05	0.000126	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—APC—stomach cancer	3.72e-05	0.000125	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—IL6—stomach cancer	3.71e-05	0.000125	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—NOS3—stomach cancer	3.69e-05	0.000124	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MMP9—stomach cancer	3.69e-05	0.000124	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—APC—stomach cancer	3.68e-05	0.000124	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTT1—stomach cancer	3.68e-05	0.000124	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CDKN1A—stomach cancer	3.67e-05	0.000124	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CCND1—stomach cancer	3.63e-05	0.000122	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP2A6—stomach cancer	3.63e-05	0.000122	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—JUN—stomach cancer	3.63e-05	0.000122	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MAPK8—stomach cancer	3.58e-05	0.000121	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—MAPK3—stomach cancer	3.57e-05	0.00012	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—MAPK3—stomach cancer	3.56e-05	0.00012	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—AKR1C3—stomach cancer	3.53e-05	0.000119	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MMP9—stomach cancer	3.53e-05	0.000119	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—MAPK3—stomach cancer	3.53e-05	0.000119	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CDKN1A—stomach cancer	3.52e-05	0.000118	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL6R—stomach cancer	3.46e-05	0.000117	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL6R—stomach cancer	3.45e-05	0.000116	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ENO1—stomach cancer	3.44e-05	0.000116	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MAPK8—stomach cancer	3.43e-05	0.000116	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL6R—stomach cancer	3.42e-05	0.000115	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—MAPK1—stomach cancer	3.4e-05	0.000115	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—EGFR—stomach cancer	3.4e-05	0.000114	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—MAPK1—stomach cancer	3.39e-05	0.000114	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—EGFR—stomach cancer	3.39e-05	0.000114	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PTGS2—stomach cancer	3.38e-05	0.000114	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—MAPK1—stomach cancer	3.36e-05	0.000113	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—EGFR—stomach cancer	3.36e-05	0.000113	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—VEGFA—stomach cancer	3.31e-05	0.000111	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—STAT3—stomach cancer	3.28e-05	0.00011	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—PIK3CA—stomach cancer	3.25e-05	0.000109	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SERPINE1—stomach cancer	3.24e-05	0.000109	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—PIK3CA—stomach cancer	3.24e-05	0.000109	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SERPINE1—stomach cancer	3.23e-05	0.000109	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—KRAS—stomach cancer	3.21e-05	0.000108	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—PIK3CA—stomach cancer	3.21e-05	0.000108	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SERPINE1—stomach cancer	3.2e-05	0.000108	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—KRAS—stomach cancer	3.2e-05	0.000108	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—KRAS—stomach cancer	3.17e-05	0.000107	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—VEGFA—stomach cancer	3.17e-05	0.000107	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—STAT3—stomach cancer	3.14e-05	0.000106	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MAPK3—stomach cancer	3.13e-05	0.000105	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—RHOA—stomach cancer	3.13e-05	0.000105	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—RHOA—stomach cancer	3.12e-05	0.000105	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NOS3—stomach cancer	3.1e-05	0.000104	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—RHOA—stomach cancer	3.09e-05	0.000104	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NOS3—stomach cancer	3.09e-05	0.000104	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NOS3—stomach cancer	3.06e-05	0.000103	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CD44—stomach cancer	3.06e-05	0.000103	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MYC—stomach cancer	3.04e-05	0.000103	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MAPK3—stomach cancer	3e-05	0.000101	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MAPK1—stomach cancer	2.98e-05	0.0001	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—EGFR—stomach cancer	2.98e-05	0.0001	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—PIK3CA—stomach cancer	2.95e-05	9.94e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—PIK3CA—stomach cancer	2.94e-05	9.9e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MYC—stomach cancer	2.92e-05	9.82e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—PIK3CA—stomach cancer	2.91e-05	9.81e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ERBB2—stomach cancer	2.9e-05	9.76e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ERBB2—stomach cancer	2.89e-05	9.73e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ERBB2—stomach cancer	2.86e-05	9.63e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MAPK1—stomach cancer	2.85e-05	9.61e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—EGFR—stomach cancer	2.85e-05	9.6e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—KRAS—stomach cancer	2.81e-05	9.47e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCL8—stomach cancer	2.75e-05	9.25e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCL8—stomach cancer	2.74e-05	9.22e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HRAS—stomach cancer	2.73e-05	9.19e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HRAS—stomach cancer	2.72e-05	9.16e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCL8—stomach cancer	2.71e-05	9.13e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HRAS—stomach cancer	2.69e-05	9.07e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—KRAS—stomach cancer	2.69e-05	9.07e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	2.68e-05	9.04e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CDKN1B—stomach cancer	2.67e-05	9.01e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CDKN1B—stomach cancer	2.65e-05	8.92e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL6—stomach cancer	2.61e-05	8.8e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL6—stomach cancer	2.6e-05	8.77e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PPP2R1A—stomach cancer	2.6e-05	8.75e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PIK3CA—stomach cancer	2.58e-05	8.7e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL6—stomach cancer	2.58e-05	8.68e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCND1—stomach cancer	2.56e-05	8.62e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—JUN—stomach cancer	2.55e-05	8.6e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCND1—stomach cancer	2.55e-05	8.59e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTP1—stomach cancer	2.55e-05	8.58e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—JUN—stomach cancer	2.55e-05	8.57e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCND1—stomach cancer	2.53e-05	8.51e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—JUN—stomach cancer	2.52e-05	8.49e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HMOX1—stomach cancer	2.51e-05	8.46e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TP53—stomach cancer	2.5e-05	8.42e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MMP9—stomach cancer	2.48e-05	8.37e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MMP9—stomach cancer	2.48e-05	8.34e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	2.48e-05	8.34e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PIK3CA—stomach cancer	2.48e-05	8.34e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CDKN1A—stomach cancer	2.47e-05	8.31e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MMP9—stomach cancer	2.45e-05	8.26e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	2.44e-05	8.23e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MAPK8—stomach cancer	2.42e-05	8.14e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MAPK8—stomach cancer	2.41e-05	8.11e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TP53—stomach cancer	2.39e-05	8.06e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HRAS—stomach cancer	2.39e-05	8.05e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MAPK8—stomach cancer	2.39e-05	8.03e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—TYMS—stomach cancer	2.37e-05	7.98e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTM1—stomach cancer	2.34e-05	7.89e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HRAS—stomach cancer	2.29e-05	7.71e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL6—stomach cancer	2.29e-05	7.71e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—VEGFA—stomach cancer	2.23e-05	7.51e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—VEGFA—stomach cancer	2.22e-05	7.49e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—STAT3—stomach cancer	2.21e-05	7.44e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—VEGFA—stomach cancer	2.2e-05	7.42e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—STAT3—stomach cancer	2.2e-05	7.42e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ERCC2—stomach cancer	2.2e-05	7.41e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL6—stomach cancer	2.19e-05	7.38e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—STAT3—stomach cancer	2.18e-05	7.35e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MAPK3—stomach cancer	2.11e-05	7.11e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MAPK3—stomach cancer	2.1e-05	7.09e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MAPK3—stomach cancer	2.08e-05	7.02e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PIK3CA—stomach cancer	2.08e-05	7e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—MTHFR—stomach cancer	2.07e-05	6.97e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MYC—stomach cancer	2.05e-05	6.91e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MYC—stomach cancer	2.05e-05	6.89e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MYC—stomach cancer	2.03e-05	6.83e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MAPK1—stomach cancer	2.01e-05	6.76e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—EGFR—stomach cancer	2.01e-05	6.76e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MAPK1—stomach cancer	2e-05	6.74e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—EGFR—stomach cancer	2e-05	6.74e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MAPK1—stomach cancer	1.98e-05	6.68e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—EGFR—stomach cancer	1.98e-05	6.68e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CAV1—stomach cancer	1.91e-05	6.43e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—APOA1—stomach cancer	1.9e-05	6.41e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—KRAS—stomach cancer	1.9e-05	6.39e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—KRAS—stomach cancer	1.89e-05	6.37e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—KRAS—stomach cancer	1.87e-05	6.31e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	1.74e-05	5.87e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PIK3CA—stomach cancer	1.74e-05	5.85e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	1.72e-05	5.79e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TP53—stomach cancer	1.69e-05	5.68e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TP53—stomach cancer	1.68e-05	5.66e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PPARG—stomach cancer	1.68e-05	5.65e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TP53—stomach cancer	1.66e-05	5.61e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HRAS—stomach cancer	1.61e-05	5.43e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HRAS—stomach cancer	1.61e-05	5.41e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HRAS—stomach cancer	1.59e-05	5.36e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL6—stomach cancer	1.54e-05	5.2e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL6—stomach cancer	1.54e-05	5.18e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL6—stomach cancer	1.52e-05	5.13e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ALB—stomach cancer	1.51e-05	5.08e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—NOS3—stomach cancer	1.44e-05	4.86e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTGS2—stomach cancer	1.32e-05	4.45e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PIK3CA—stomach cancer	8.12e-06	2.74e-05	CbGpPWpGaD
